UTI. Calculus of kidney and ureter
Conditions
Interventions
Intervention 1: Patients are divided into two groups of A and B. Group A (the intervention group) will be given 200 mg of Ofloxacin every 12 hours. Intervention 2: Group B ( control group) will be giv
Treatment - Drugs
Placebo
Patients are divided into two groups of A and B. Group A (the intervention group) will be given 200 mg of Ofloxacin every 12 hours.
Group B ( control group) will be given placebo which is a pill made from flour.
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: minimum age 18 years; negative urine culture before ESWL; absence of Foley catheter or nephrostomy tube; no history of infectious stones. Exclusion criteria: patients who have not had suitable follow up; those who have done urine culture in the 2 weeks after ESWL; manipulation of the urinary system during and after ESWL.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of urinary tract infections was measured among patients without risk factors. Timepoint: Urine analysis was performed 5 days before ESWL surgery. Method of measurement: Calculate number organisms in the urine according to CFU. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increased antibiotic resistance and drug side effects and interactions compared with placebo has occurred. Timepoint: monthly. Method of measurement: Urine culture and physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Shafie
Babol University of Medical Sciences
Outcome results
None listed